Mortazavi, Seyed Alireza, Jooyan, Najme, Baha’addini Baigy Zarandi, Batool Faegheh, Jooyan, Neda, Faraz, Mehdi, Mortazavi, Seyed Mohammad Javad. (1401). Coming Out of Nowhere: The Paradox of the Birth of Omicron. سامانه مدیریت نشریات علمی, 12(4), 325-326. doi: 10.31661/jbpe.v0i0.2202-1456
Seyed Alireza Mortazavi; Najme Jooyan; Batool Faegheh Baha’addini Baigy Zarandi; Neda Jooyan; Mehdi Faraz; Seyed Mohammad Javad Mortazavi. "Coming Out of Nowhere: The Paradox of the Birth of Omicron". سامانه مدیریت نشریات علمی, 12, 4, 1401, 325-326. doi: 10.31661/jbpe.v0i0.2202-1456
Mortazavi, Seyed Alireza, Jooyan, Najme, Baha’addini Baigy Zarandi, Batool Faegheh, Jooyan, Neda, Faraz, Mehdi, Mortazavi, Seyed Mohammad Javad. (1401). 'Coming Out of Nowhere: The Paradox of the Birth of Omicron', سامانه مدیریت نشریات علمی, 12(4), pp. 325-326. doi: 10.31661/jbpe.v0i0.2202-1456
Mortazavi, Seyed Alireza, Jooyan, Najme, Baha’addini Baigy Zarandi, Batool Faegheh, Jooyan, Neda, Faraz, Mehdi, Mortazavi, Seyed Mohammad Javad. Coming Out of Nowhere: The Paradox of the Birth of Omicron. سامانه مدیریت نشریات علمی, 1401; 12(4): 325-326. doi: 10.31661/jbpe.v0i0.2202-1456
Coming Out of Nowhere: The Paradox of the Birth of Omicron
Mallapaty S. Where did COVID come from? Five mysteries that remain. 2021;591(7849):188-9. doi: 10.1038/d41586-021-00502-4. PubMed PMID: 33637873.
Mallapaty S. Where did Omicron come from? Three key theories. Nature. 2022;602(7895):26-8. doi: 10.1038/d41586-022-00215-2. PubMed PMID: 35091701.
Martin DP, Lytras S, Lucaci AG, et al. Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function. BioRxiv. 2022. doi: 10.1101/2022.01.14.476382. PubMed PMID: 35075456. PubMed PMCID: PMC8786225.
Callaway E, Ledford H. How bad is Omicron? What scientists know so far. Nature. 2021;600(7888):197-99. doi: 10.1038/d41586-021-03614-z. PubMed PMID: 34857948.
Oberemok VV, Laikova KV, Yurchenko KA, et al. SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship. Inflamm Res. 2020;69(7):635-40. doi: 10.1007/s00011-020-01352-y. PubMed PMID: 32350571. PubMed PMCID: PMC7190393.
Bevelacqua JJ, Mortazavi SMJ. Don’t worry! The next generation would be more resistant to SARS-CoV-2. Inflamm Res. 2020;69(12):1159-61. doi: 10.1007/s00011-020-01405-2. PubMed PMID: 32989506. PubMed PMCID: PMC7521771.
Catanzaro M, Fagiani F, Racchi M, et al. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Ther. 2020;5(1):84. doi: 10.1038/s41392-020-0191-1. PubMed PMID: 32467561. PubMed PMCID: PMC7255975.
Kupferschmidt K. The pandemic virus is slowly mutating. But does it matter? Science. 2020;369(6501):238-9. doi: 10.1126/science.369.6501.238. PubMed PMID: 32675355.
Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457-60. doi: 10.1007/s11427-020-1637-5. PubMed PMID: 32009228. PubMed PMCID: PMC7089049.
Mortazavi SAR, Bevelacqua JJ, Welsh JS, et al. The Paradox of COVID-19 in Sub-Saharan Africa: Why it is More Unethical not to Investigate Low Dose Radiotherapy for COVID-19. J Biomed Phys Eng. 2022.
Mortazavi SAR, Mortazavi SMJ, Sihver L. Selective Pressure-Free Treatments for COVID-19. Radiation. 2021;1(1):18-32. doi: 10.3390/radiation1010003.
Mehdizadeh AR, Bevelacqua JJ, Mortazavi SAR, Mortazavi SMJ. COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New Mutations. J Biomed Phys Eng. 2020;10(3):247-50. doi: 10.31661/jbpe.v0i0.2005-1114. PubMed PMID: 32637368. PubMed PMCID: PMC7321390.
Mortazavi SMJ, Kefayat A, Cai J. Low dose radiation as a treatment for COVID-19 pneumonia: a threat or real opportunity? Medical physics. 2020;47(9): 3773-6. doi: 10.1002/mp.14367.
Cuttler JM, Bevelacqua JJ, Mortazavi SMJ. Unethical not to Investigate Radiotherapy for COVID-19. Dose Response. 2020;18(3):1559325820950104. doi: 10.1177/1559325820950104. PubMed PMID: 32868978. PubMed PMCID: PMC7435205.